moxifloxacin has been researched along with Corneal Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mansoori, T; Reddy, AK; Sistla, A; Srirampur, A; Suresh, N | 1 |
| Chang, MC; Chen, KY; Hung, KH; Kuo, YJ; Peng, CL; Yeh, LK | 1 |
| Cherof, AM; Kahook, MY; Seibold, LK; SooHoo, JR | 1 |
| Chew, J; Hunter, B; Jensen, M; Kleinmann, G; Mamalis, N; Meyer, JJ; Moshirfar, M; Stevens, S; Werner, L | 1 |
| El-Adly, AA; El-Laithy, HM; Nesseem, DI; Shoukry, M | 1 |
| Furukawa, T; Goto, H; Ito, N; Miyake, T; Tajima, K | 1 |
| de Oliveira, LA; de Sousa, LB; do Nascimento, HM; Ecker, DJ; Magalhães, FP; Rosenblatt, MI; Sampath, R; Sannes-Lowery, KA | 1 |
| Barequet, IS; Belkin, M; Habot-Wilner, Z; Lavinsky, F; Rosner, M; Ziv, H | 1 |
8 other study(ies) available for moxifloxacin and Corneal Diseases
| Article | Year |
|---|---|
Retrocorneal abscess: an unusual presentation of Nocardia keratitis after Descemet's stripping endothelial keratoplasty.
Topics: Abscess; Aged, 80 and over; Anti-Bacterial Agents; Antihypertensive Agents; Atropine; Corneal Diseases; Descemet Stripping Endothelial Keratoplasty; Eye Infections, Bacterial; Female; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Mydriatics; Nocardia; Nocardia Infections; Postoperative Complications; Slit Lamp Microscopy; Tomography, Optical Coherence; Visual Acuity | 2020 |
Liposomal dexamethasone-moxifloxacin nanoparticle combinations with collagen/gelatin/alginate hydrogel for corneal infection treatment and wound healing.
Topics: Alginates; Animals; Anti-Inflammatory Agents; Bacillus; Biocompatible Materials; Collagen; Cornea; Corneal Diseases; Dexamethasone; Drug Delivery Systems; Edema; Epithelial Cells; Escherichia coli; Gelatin; Humans; Hydrogels; Inflammation; Lipids; Liposomes; Mice; Mice, Inbred C57BL; Moxifloxacin; Particle Size; Time Factors; Wound Healing | 2020 |
Endophthalmitis With Corneal Infiltrate After EX-PRESS Glaucoma Drainage Device Implantation.
Topics: Alkylating Agents; Anti-Bacterial Agents; Corneal Diseases; Device Removal; Drug Combinations; Endophthalmitis; Fluoroquinolones; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Moxifloxacin; Prednisolone | 2016 |
Comparison of the effects of fourth-generation fluoroquinolones on corneal re-epithelialization in rabbit eyes.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Aza Compounds; Benzalkonium Compounds; Corneal Diseases; Disease Models, Animal; Epithelium, Corneal; Ethanol; Female; Fluoroquinolones; Gatifloxacin; Image Processing, Computer-Assisted; Male; Moxifloxacin; Ophthalmic Solutions; Preservatives, Pharmaceutical; Prospective Studies; Quinolines; Rabbits; Wound Healing | 2008 |
Moxifloxacin-Gelrite in situ ophthalmic gelling system against photodynamic therapy for treatment of bacterial corneal inflammation.
Topics: Adhesiveness; Animals; Anti-Bacterial Agents; Aqueous Humor; Area Under Curve; Aza Compounds; Bacterial Infections; Bacterial Load; Chemistry, Pharmaceutical; Cornea; Corneal Diseases; Escherichia coli; Excipients; Fluoroquinolones; Gels; Keratitis; Light; Male; Microbial Sensitivity Tests; Moxifloxacin; Mucous Membrane; Ophthalmic Solutions; Osmotic Pressure; Photochemotherapy; Polysaccharides, Bacterial; Quinolines; Rabbits; Reference Standards; Spectrometry, Fluorescence; Staphylococcus aureus; Viscosity | 2011 |
Comparison of moxifloxacin and levofloxacin in an epithelial disorder model using cultured rabbit corneal epithelial cell sheets.
Topics: Amnion; Animals; Anti-Bacterial Agents; Aza Compounds; Cells, Cultured; Corneal Diseases; Epithelium, Corneal; Female; Fluoroquinolones; Levofloxacin; Models, Biological; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Preservatives, Pharmaceutical; Quinolines; Rabbits; Swine; Wound Healing | 2012 |
Microbiota evaluation of patients with a Boston type I keratoprosthesis treated with topical 0.5% moxifloxacin and 5% povidone-iodine.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Aza Compounds; Corneal Diseases; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Molecular Diagnostic Techniques; Moxifloxacin; Povidone-Iodine; Prospective Studies; Prostheses and Implants; Quinolines; Staphylococcus aureus | 2013 |
Effect of fourth-generation fluoroquinolones on the healing rate of corneal erosions in an animal model.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Corneal Diseases; Disease Models, Animal; Epithelium, Corneal; Fluoroquinolones; Gatifloxacin; Male; Moxifloxacin; Quinolines; Rabbits; Wound Healing | 2007 |